These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3410804)

  • 1. Long-term oral ciprofloxacin therapy in a cystic fibrosis patient.
    Willems FT; Haverman FE
    J Antimicrob Chemother; 1988 Jun; 21(6):810-1. PubMed ID: 3410804
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].
    Magni A; Pradal U; Cazzola G; Mastella G
    Pediatr Med Chir; 1990; 12(5):531-4. PubMed ID: 2087426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis.
    Hodson ME; Roberts CM; Butland RJ; Smith MJ; Batten JC
    Lancet; 1987 Jan; 1(8527):235-7. PubMed ID: 2880066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa.
    Sheldon CD; Assoufi BK; Hodson ME
    Respir Med; 1993 Nov; 87(8):587-93. PubMed ID: 8290742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin in cystic fibrosis.
    Smith MJ; Hodson ME; Batten JC
    Lancet; 1986 May; 1(8489):1103. PubMed ID: 2871373
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection.
    Strandvik B; Hjelte L; Lindblad A; Ljungberg B; Malmborg AS; Nilsson-Ehle I
    Scand J Infect Dis Suppl; 1989; 60():84-8. PubMed ID: 2756354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin pharmacokinetics in young cystic fibrosis patients after repeated oral doses.
    Odoul F; Le Guellec C; Giraut C; de Gialluly C; Marchand S; Paintaud G; Saux MC; Rolland JC; Autret-Leca E
    Therapie; 2001; 56(5):519-24. PubMed ID: 11806288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.
    Connett GJ; Pike KC; Legg JP; Cathie K; Dewar A; Foote K; Harris A; Faust SN
    Ther Adv Respir Dis; 2015 Dec; 9(6):272-80. PubMed ID: 26341118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.
    Guillot E; Sermet I; Ferroni A; Chhun S; Pons G; Zahar JR; Jullien V
    Pharmacotherapy; 2010 Dec; 30(12):1252-8. PubMed ID: 21114393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of ciprofloxacin in children with cystic fibrosis.
    Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
    Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
    [No Abstract]   [Full Text] [Related]  

  • 11. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
    Griese M; Müller I; Reinhardt D
    Eur J Med Res; 2002 Feb; 7(2):79-80. PubMed ID: 11891148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.
    Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R
    J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
    Christensson BA; Nilsson-Ehle I; Ljungberg B; Lindblad A; Malmborg AS; Hjelte L; Strandvik B
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2512-7. PubMed ID: 1489195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.
    Goldfarb J; Stern RC; Reed MD; Yamashita TS; Myers CM; Blumer JL
    Am J Med; 1987 Apr; 82(4A):174-9. PubMed ID: 3555032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ciprofloxacin therapy in cystic fibrosis.
    Scully BE; Nakatomi M; Ores C; Davidson S; Neu HC
    Am J Med; 1987 Apr; 82(4A):196-201. PubMed ID: 3555036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of two dosage regimens of ciprofloxacin for treating chronic bronchopulmonary infection in patients with cystic fibrosis.
    Shalit I; Stutman HR; Marks MI; Chartrand SA; Hilman BC
    Am J Med; 1987 Apr; 82(4A):189-95. PubMed ID: 3555035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.
    Rubio TT; Shapiro C
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():147-52. PubMed ID: 3100490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulopathy in two patients with cystic fibrosis treated with ciprofloxacin.
    Moore GC; Redfern J; Shiach CR; Webb K; Jones AM
    J Cyst Fibros; 2007 May; 6(3):209-11. PubMed ID: 17045852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin therapy in cystic fibrosis.
    Raeburn JA; Govan JR; McCrae WM; Greening AP; Collier PS; Hodson ME; Goodchild MC
    J Antimicrob Chemother; 1987 Sep; 20(3):295-6. PubMed ID: 3680073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.